Sinhang Cheng is currently an MB candidate at Peking University, Beijing, China, where she is expected to receive her MB degree in 2028. Her research focuses on microbiome-targeted interventions, with a particular interest in the role of the gut microbiome in gastrointestinal cancer therapy and the development of microbiota-based therapeutic strategies. She has engaged in literature research on microbiome modulation and its clinical translation, and is committed to pursuing a career in translational medicine.
Peking University Third Hospital
Beijing, China
Aerospace Center Hospital
Beijing, China